Biosyent Inc. (RX : TSX-V)
Common Stock
$14.66
CAD
-0.09 (-0.61%)
Last updated: 2026-07-29
Get RX alerts:
RX
Biosyent Inc.
WealthAwesomePerformance
1 Day
+0.00%
1 Week
-0.20%
1 Month
+1.10%
YTD
+14.89%
Key Statistics
Market Cap
$166.13M
52W High
$15.73
52W Low
$10.52
P/E Ratio
18.79
50 Day MA
$14.22
200 Day MA
$13.56
Beta
0.63
Dividend Yield
1.40%
Advertisement
Biosyent Inc. insider transactions
Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.
Recent transactions
| Date | Side | Name | Shares | Price |
|---|---|---|---|---|
| Jun 23, 26 | Sell | Goehrum, Rene Individual · CA$76,798 | 5,525 | CA$13.90 |
| Jun 22, 26 | Sell | Lockhard, Peter Douglas Individual · CA$1,036 | 74 | CA$14.00 |
| Jun 18, 26 | Sell | Lockhard, Peter Douglas Individual · CA$8,400 | 600 | CA$14.00 |
| Jun 11, 26 | Sell | Lockhard, Peter Douglas Individual · CA$4,200 | 300 | CA$14.00 |
| Jun 11, 26 | Sell | Lockhard, Peter Douglas Individual · CA$4,230 | 300 | CA$14.10 |
| Jun 10, 26 | Sell | Lockhard, Peter Douglas Individual · CA$4,170 | 300 | CA$13.90 |
| Jun 10, 26 | Sell | Lockhard, Peter Douglas Individual · CA$4,200 | 300 | CA$14.00 |
| May 29, 26 | Sell | Lockhard, Peter Douglas Individual · CA$2,810 | 200 | CA$14.05 |
| May 28, 26 | Sell | Lockhard, Peter Douglas Individual · CA$1,405 | 100 | CA$14.05 |
| May 26, 26 | Sell | Lockhard, Peter Douglas Individual · CA$4,155 | 300 | CA$13.85 |
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/29/2026 | $14.70 | $14.75 | $14.66 | $14.66 | $14.66 | 1,258 |
| 7/28/2026 | $14.75 | $14.75 | $14.75 | $14.75 | $14.75 | 1,810 |
| 7/27/2026 | $14.74 | $14.75 | $14.62 | $14.74 | $14.74 | 4,040 |
| 7/24/2026 | $14.61 | $14.74 | $14.60 | $14.74 | $14.74 | 907 |
| 7/23/2026 | $14.55 | $14.69 | $14.54 | $14.69 | $14.69 | 1,800 |
| 7/22/2026 | $14.70 | $14.70 | $14.54 | $14.54 | $14.54 | 8,087 |
| 7/21/2026 | $14.54 | $14.70 | $14.54 | $14.70 | $14.70 | 3,046 |
| 7/20/2026 | $14.50 | $14.75 | $14.50 | $14.50 | $14.50 | 5,882 |
| 7/17/2026 | $14.54 | $14.60 | $14.50 | $14.50 | $14.50 | 3,805 |
| 7/16/2026 | $14.60 | $14.64 | $14.50 | $14.50 | $14.50 | 6,621 |
Analyst Price Targets
Based on analyst covering RX
Wall Street analysts forecast RX stock price to rise 22.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.00
+22.8% Upside
Current Price
C$14.66
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RX's historical volatility
30-Day Vol
17.1%
Annualized
90-Day Vol
19.9%
Annualized
Trend (90d)
+10.1%
Annualized drift
90d Mean
C$15.20
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$14.84 | C$13.99 – C$15.74 |
| 60 trading days | C$15.02 | C$13.82 – C$16.32 |
| 90 trading days | C$15.20 | C$13.73 – C$16.83 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Biosyent Inc.
BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. BioSyent Inc. was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. The company was incorporated in 2006 and is headquartered in Mississauga, Canada.
Financials
- Revenue (TTM)
- $45.98M
- EBITDA
- $12.55M
- Profit Margin
- 19.65%
- ROE (TTM)
- 22.31%
- EPS (Diluted)
- 0.78
- Book Value
- 3.94
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Recent Dividends
$0.0550CAD
Ex: May 29, 2026
$0.0550CAD
Ex: Feb 27, 2026
$0.0450CAD
Ex: Nov 29, 2024
$0.0450CAD
Ex: Sep 4, 2024
$0.0450CAD
Ex: May 31, 2024
$0.0450CAD
Ex: Feb 28, 2024
$0.0400CAD
Ex: Nov 29, 2023
$0.0400CAD
Ex: Aug 30, 2023
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About RX
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| BIGT | Big Tree Carbon Inc. | $0.02 | +100.00% |
| CSTR | CryptoStar Corp | $0.01 | +100.00% |
| MAN-P | Mandala Capital Inc. | $0.06 | +100.00% |
| NOB | Noble Mineral Exploration Inc | $0.09 | +70.00% |
| FRNT | FRNT Financial Inc | $0.10 | +33.33% |
| BECN | BEACN Wizardry & Magic Inc | $0.04 | +33.33% |
| PPM | Pacific Imperial Mines Inc | $0.02 | +33.33% |
| BIG | Hercules Metals Corp. | $0.77 | +30.51% |